Keywords: epix, begins, study, mri, clot, diagnostic, pharmaceuticals

EPIX begins study of MRI clot diagnostic

Article | 18 April 2005

Print This

EPIX Pharmaceuticals, a USA-based developer of drugs that aid magnetic resonance imaging, has initiated a Phase II proof-of-concept trial for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in